Literature DB >> 28361419

Association of Glu298Asp Polymorphism of Endothelial NO Synthase Gene with Metabolic Syndrome Development: a Pilot Study.

N S Fattakhov1,2, D A Skuratovskaya3, M A Vasilenko3, E V Kirienkova3, P A Zatolokin4, N I Mironyuk4, L S Litvinova3.   

Abstract

We studied association of single nucleotide polymorphism Glu298Asp (rs1799983) of the NOS3 gene with the risk of metabolic syndrome in the Slavic population. Blood samples were obtained from 128 patients with metabolic syndrome and 100 healthy individuals. Polymorphism Glu298Asp of the NOS3 gene was genotyped by allele-specific PCR. Allele Asp (OR=1.95, 95%CI 1.29-2.95, p=0.007) and genotype Asp/Asp (OR=2.56, 95%CI 0.98-6.72, p=0.04) were associated with the risk of metabolic syndrome in Slavic population. Patients with metabolic syndrome carrying genotype Asp/Asp had higher serum endothelin-1 level in comparison with Glu/Asp and Glu/Glu carriers.

Entities:  

Keywords:  endothelial NO synthase; endothelial dysfunction; metabolic syndrome; nitric oxide; single nucleotide polymorphism

Mesh:

Substances:

Year:  2017        PMID: 28361419     DOI: 10.1007/s10517-017-3670-9

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  2 in total

1.  Comparative Informativity of Computing Methods of Insulin Resistance Assessment.

Authors:  S I Kseneva; E V Borodulina; O Yu Trifonova; V P Fisenko; V V Udut
Journal:  Bull Exp Biol Med       Date:  2022-01-10       Impact factor: 0.804

2.  Association of NOS3-c.894G>T transversion with susceptibility to metabolic syndrome in Azar-cohort population: A case-control study and in silico analysis of the SNP molecular effects.

Authors:  Ensiyeh Seyedrezazadeh; Elnaz Faramarzi; Nasim Bakhtiyari; Atefeh Ansarin; Neda Gilani; Amir Amiri-Sadeghan; Maryam Seyyedi; Khalil Ansarin; Younes Aftabi
Journal:  Iran J Basic Med Sci       Date:  2021-03       Impact factor: 2.699

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.